EA202191299A1 - Способы применения обетихолевой кислоты - Google Patents

Способы применения обетихолевой кислоты

Info

Publication number
EA202191299A1
EA202191299A1 EA202191299A EA202191299A EA202191299A1 EA 202191299 A1 EA202191299 A1 EA 202191299A1 EA 202191299 A EA202191299 A EA 202191299A EA 202191299 A EA202191299 A EA 202191299A EA 202191299 A1 EA202191299 A1 EA 202191299A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
acid
obetcholic
application
regress
Prior art date
Application number
EA202191299A
Other languages
English (en)
Inventor
Джеффри Эдвардс
Шэрон Каран
Джейсон Кампанья
Ли Макконелл
Original Assignee
Интерсепт Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интерсепт Фармасьютикалз, Инк. filed Critical Интерсепт Фармасьютикалз, Инк.
Publication of EA202191299A1 publication Critical patent/EA202191299A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Описание относится к способам использования обетихолевой кислоты, или фармацевтически приемлемой соли таковой, или аминокислотного конъюгата таковой для регрессии или замедления прогрессирования компенсированного цирроза.
EA202191299A 2018-11-08 2019-11-06 Способы применения обетихолевой кислоты EA202191299A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862757253P 2018-11-08 2018-11-08
PCT/US2019/060014 WO2020097167A1 (en) 2018-11-08 2019-11-06 Methods of using obeticholic acid

Publications (1)

Publication Number Publication Date
EA202191299A1 true EA202191299A1 (ru) 2021-07-26

Family

ID=70551387

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191299A EA202191299A1 (ru) 2018-11-08 2019-11-06 Способы применения обетихолевой кислоты

Country Status (12)

Country Link
US (2) US20200147108A1 (ru)
EP (1) EP3876944A4 (ru)
JP (1) JP2022506782A (ru)
KR (1) KR20210089705A (ru)
CN (1) CN113271951A (ru)
AU (1) AU2019374797A1 (ru)
BR (1) BR112021008015A2 (ru)
CA (1) CA3117966A1 (ru)
EA (1) EA202191299A1 (ru)
IL (1) IL282642A (ru)
MX (1) MX2021005316A (ru)
WO (1) WO2020097167A1 (ru)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3028207A1 (en) * 2012-06-19 2013-12-27 Intercept Pharmaceuticals, Inc. Preparation, uses and solid forms of obeticholic acid
PE20180690A1 (es) * 2015-04-27 2018-04-23 Intercept Pharmaceuticals Inc Composiciones de acido obeticolico y metodos de uso
CZ2015504A3 (cs) * 2015-07-16 2017-01-25 Zentiva, K.S. Krystalické formy obeticholové kyseliny
EP3437659B1 (en) * 2016-03-28 2023-03-01 Intercept Pharmaceuticals, Inc. Combination of a fxr agonist and an angiotensin ii receptor blocker
CN108114284A (zh) * 2016-11-30 2018-06-05 中国药科大学 Fxr激动剂与凋亡抑制剂联用在制备优效抗肝纤维化药物中的应用
CA3047591A1 (en) * 2016-12-28 2018-07-05 Modunex Bio Corp. Combination therapy for nonalcoholic steatohepatitis (nash) and liver fibrosis

Also Published As

Publication number Publication date
IL282642A (en) 2021-06-30
EP3876944A4 (en) 2022-08-10
US20220184099A1 (en) 2022-06-16
WO2020097167A1 (en) 2020-05-14
CN113271951A (zh) 2021-08-17
BR112021008015A2 (pt) 2021-08-03
AU2019374797A1 (en) 2021-05-27
EP3876944A1 (en) 2021-09-15
JP2022506782A (ja) 2022-01-17
KR20210089705A (ko) 2021-07-16
US20200147108A1 (en) 2020-05-14
CA3117966A1 (en) 2020-05-14
MX2021005316A (es) 2021-09-10

Similar Documents

Publication Publication Date Title
EA201892007A1 (ru) 3-дезоксипроизводное и фармацевтические композиции на его основе
EA201890899A1 (ru) Модуляторы фарнезоидного x-рецептора
EA201991693A1 (ru) Производное пиридина в качестве ингибитора ask1 и способ его получения и применения
BR112019003637A2 (pt) um esteróide 19-nor c3,3-dissubstituído c21-n-pirazolil cristalino
EA201892128A1 (ru) Гетероциклические амиды, полезные в качестве модуляторов
MX2018001491A (es) Metodos para la preparacion de acidos biliares y derivados de los mismos.
EA201891342A1 (ru) Изоиндольные соединения
MD3416631T2 (ro) Agenți terapeutici pentru bolile neurodegenerative
EA202090620A1 (ru) Энантиомеры замещенных тиазолов в качестве противовирусных соединений
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
EA201600088A1 (ru) Парентеральное введение тапентадола
CY1124251T1 (el) Παραγωγα καρβοξαμιδιου
EA202092849A1 (ru) Моноспецифические и мультиспецифические антитела к tmeff2 и их применение
EA201791807A1 (ru) Новый тритерпенон по с-3 с обратными амидными производными по с-17 в качестве ингибиторов вич
CY1125355T1 (el) Πεντακυκλικη ενωση
EA201692518A2 (ru) Способы улучшения производительности миокарда у пациентов после операции фонтена с применением композиций уденафила
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы
EA201992233A1 (ru) Соединения изоксазолкарбоксамида и их применение
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
CY1122375T1 (el) Συμπυκνωμενα με τετραϋδροφουρανιο αμινοϋδροθειαζινικα αναλογα τα οποια ειναι χρησιμα στη θεραπεια της νοσου toy alzheimer
EA201891431A1 (ru) Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина
PH12021550452A1 (en) Methods of treating mycobacterial infections using tetracycline compounds
EA201991373A1 (ru) МОДУЛЯТОРЫ ROR ГАММА (RORγ)
PH12017501869A1 (en) (s)-2'-vinyl-abscisic acid derivatives
EA201990766A1 (ru) Индазольные соединения для применения при повреждениях сухожилий и/или связок